Abstract
The extent and mode of solubility enhancement exerted by the cyclodextrins (α-, β-, γ-, and HP-β-CDs) on loratadine (Lort) have been experimentally measured under controlled conditions in buffered aqueous solutions. Rigorous nonlinear regression analysis of the phase solubility diagrams obtained in 0.1 mol⋅L−1 phosphate buffer at pH=7.0 and 25 °C revealed the following: neutral Lort (pK a =4.6) tends to form soluble 1:1 and 1:2 Lort/CD complexes with all four of the examined CDs, where complex stability follows the decreasing order β-CD>HP-β-CD>γ-CD>α-CD. The hydrophobic character of Lort constitutes about 66% of the driving force for complex formation whereas specific interactions contribute 11.2 kJ⋅mol−1 towards the stability of the complexes. Thermodynamic studies showed that Lort/CD complex formation was favored by large enthalpic contributions but was impeded by negative entropic changes. Dissolution studies indicate that the dissolution rate of Lort from the freeze-dried Lort/β-CD complex is significantly higher than that of the corresponding physical mixture. Both DSC studies and molecular mechanical modeling of Lort/β-CD interactions were carried out to explore the possible formation of inclusion complexes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Duchene, D.: Cyclodextrins and their industrial uses. Editions de Sante’, Paris (1987)
Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743–1754 (1998)
Tabushi, I., Kiyosuke, Y., Sugimoto, T., Yamamura, K.: Approach to the aspects of driving force of inclusion by α-cyclodextrin. J. Am. Chem. Soc. 100, 916–919 (1978)
Rekharsky, M.V., Inoue, Y.: Complexation thermodynamics of cyclodextrins. Chem. Rev. 98, 1875–1918 (1998)
Duchene, D., Wouessidjewe, D.: Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm. 16, 2487–2499 (1990)
Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996)
Hedges, A.R.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035–2044 (1998)
Mura, P., Maestrelli, F., Cirri, M.: Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids. Int. J. Pharm. 260, 293–302 (2003)
Ter Lack, A.M., Tsai, R.S., Donne-Op den Kelder, G.M., Carrupt, P.-A., Testa, B., Timmerman, H.: Lipophilicity and bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects. Eur. J. Pharm. Sci. 2, 373–384 (1994)
Ter Lack, A.M., Bijloo, G.J., Fischer, M.J.E., Donneop den Kelder, G.M., Wilting, J., Timmerman, H.: Serum protein binding of histamine H1-antagonists. A comparative study on the serum protein binding of a sedating ([3H]mepyramine) and a non-sedating H1-antagonist ([3H]loratadine). Eur. J. Pharm. Sci. 4, 307–319 (1996)
Seghal, A., Srivastava, J., Arora, V.K.: Nasal pharmaceutical compositions of loratadine. Patent No. WO 2004082589 A2. Application No. WO 2004-IB839 (2004)
Abdel-Rahman, S.I., Ahmad, S.M., Samy, I.M., Badawy, A.M.M.: Interactions of loratadine with cyclodextrins. Ethiop. Pharm. J. 17, 1–19 (1999)
Zughul, M.B., Badwan, A.A.: SL2 type phase solubility diagrams, complex formation and chemical speciation of soluble species. J. Incl. Phenom. Mol. Recognit. Chem. 31, 243–264 (1998)
Zughul, M.B., Badwan, A.A.: Rigorous analysis of S2L-type phase solubility diagrams to obtain individual formation and solubility product constants of both SL and S2L-type complexes. Int. J. Pharm. 151, 109–119 (1997)
Zughul, M.B., Al-Omari, M., Badwan, A.A.: Thermodynamics of propyl paraben/β-cyclodextrin inclusion complexes. Pharm. Dev. Tech. 3, 43–53 (1998)
El-Barghouthi, M.I., Masoud, N.A., Al-Kafawein, J.K., Zughul, M.B., Badwan, A.A.: Host-guest interactions of risperidone with natural and modified cyclodextrins: phase solubility, thermodynamics and molecular modeling studies. J. Incl. Phenom. Macrocycl. Chem. 53, 15–22 (2005)
Higuchi, T., Connors, K.A.: Phase solubility techniques. In: Reilly, C.N. (ed.) Advances in Analytical Chemistry and Instrumentation, vol. 4, pp. 117–212 (1965)
Kopecky, F., Kopecka, B., Kaclik, P.: Solubility study of nimodipine inclusion complexation with α- and β-cyclodextrin and some substituted cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 39, 215–217 (2001)
Puliti, R., Mattia, C.A., Paduano, L.: Crystal structure of a new α-cyclodextrin hydrate form. Molecular geometry and packing features: disordered solvent contribution. Carbohydr. Res. 310, 1–8 (1998)
Linder, K., Saenger, W.: Crystal and molecular structure of cyclohepta-amylose dodecahydrate. Carbohydr. Res. 99, 103–115 (1982)
Saenger, W., Jacob, J., Gessler, K., Steiner, T., Hoffman, D., Sanbe, H., Koizumi, K., Smith, S.M., Takaha, T.: Structure of the common cyclodextrins and their larger analogues-beyond doughnut. Chem. Rev. 98, 1787–1802 (1998)
Harata, K.: The structure of the cyclodextrin complex. 20. Crystal-structure of uncomplexed hydrated gamma-cyclodextrin. Bull. Chem. Soc. Jpn. 60, 2763–2767 (1987)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Omar, L., El-Barghouthi, M.I., Masoud, N.A. et al. Inclusion Complexation of Loratadine with Natural and Modified Cyclodextrins: Phase Solubility and Thermodynamic Studies. J Solution Chem 36, 605–616 (2007). https://doi.org/10.1007/s10953-007-9136-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10953-007-9136-3